409 related articles for article (PubMed ID: 27070574)
1. Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.
Bourguignon LY
Int J Mol Sci; 2016 Apr; 17(4):517. PubMed ID: 27070574
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
Bourguignon LY; Wong G; Shiina M
J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
[TBL] [Abstract][Full Text] [Related]
3. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Bourguignon LY; Shiina M; Li JJ
Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression.
Bourguignon LY
Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418
[TBL] [Abstract][Full Text] [Related]
6. Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression.
Bourguignon LYW
Front Oncol; 2019; 9():492. PubMed ID: 31293964
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
Ju SY; Chiou SH; Su Y
Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
[TBL] [Abstract][Full Text] [Related]
8. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
[TBL] [Abstract][Full Text] [Related]
9. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.
Chen L; Bourguignon LY
Mol Cancer; 2014 Mar; 13():52. PubMed ID: 24606718
[TBL] [Abstract][Full Text] [Related]
11. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
[TBL] [Abstract][Full Text] [Related]
14. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
15. Niche Mimicking for Selection and Enrichment of Liver Cancer Stem Cells by Hyaluronic Acid-Based Multilayer Films.
Lee IC; Chuang CC; Wu YC
ACS Appl Mater Interfaces; 2015 Oct; 7(40):22188-95. PubMed ID: 26379083
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
Hiraga T; Ito S; Nakamura H
Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
19. Role of Pericellular Matrix in the Regulation of Cancer Stemness.
Avnet S; Cortini M
Stem Cell Rev Rep; 2016 Aug; 12(4):464-75. PubMed ID: 27193782
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.
Bourguignon LY
Semin Cancer Biol; 2008 Aug; 18(4):251-9. PubMed ID: 18450475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
